Scopolamine Patch, Extended Release
Product Images NDC 72162-2453

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 72162-2453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Extended Label (Lbl713352453extendedlabel)

This text provides instructions on the dosage and administration of a transdermal system. It emphasizes the importance of cleanliness, using only one system at a time, not cutting the system, applying to the hairless area behind one ear, and washing hands after application. This information is essential for proper use of the transdermal system.*

FDA Label Image

Label (Lbl721622453)

Each transdermal system contains 1.3 mg of scopolamine designed to deliver approximately 1 mg over 3 days. The inactive components include crospovidone, isopropyl palmitate, light mineral oil, polyethylene polyisobutylene, polypropylene, siliconized PET-film, and aluminized PET film. The package insert features a QR code for prescribing information. It is advised to store the system upright at 20°C to 25°C (68°F to 77°F). Caution: it may cause drowsiness and blurred vision. The foil should be sealed before use. To avoid burns, remove the system before an MRI procedure.*

FDA Label Image

Chemical Structure (Scopolamine 01)

FDA Label Image

Image (Scopolamine 02)

This text describes different layers of a drug delivery system, including the backing membrane, drug layer, rate controlling membrane, and contact layer. It also mentions a release liner, which may be used to protect the drug layers during storage and transport. It seems to be part of a pharmaceutical or medical device product description.*

FDA Label Image

Figure 1 (Scopolamine 03)

This is a disposable release liner with a metallic adhesive surface and a tan backing membrane. It features an imprint that reads 'Scopolamine 1mg/3 days'. The item is shown in Figure 1.*

FDA Label Image

Figure 2 (Scopolamine 04)

FDA Label Image

Figure 3 (Scopolamine 05)

FDA Label Image

Figure 4 (Scopolamine 06)

This text describes a tan-colored transdermal system with a metallic adhesive surface. It comes with a clear and disposable release liner. The image referenced in the text is Figure 4.*

FDA Label Image

Figure 5 (Scopolamine 07)

This is a tan-colored transdermal system imprinted with a design shown in Figure 5.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.